Advertisement

Topics

Pfizer Receives EU Approval for Besponsa Leukemia Treatment

10:09 EDT 3 Jul 2017 | PharmPro

Besponsa approved in the EU for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It provides patients who are battling an especially hard-to-treat leukemia with a new treatment option beyond chemotherapy.
Contributed Author: 
Pfizer Inc.
Topics: 

Original Article: Pfizer Receives EU Approval for Besponsa Leukemia Treatment

NEXT ARTICLE

More From BioPortfolio on "Pfizer Receives EU Approval for Besponsa Leukemia Treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...